The University of Chicago Header Logo

Connection

Katharine Yao to Prognosis

Back to Details
This is a "connection" page, showing publications Katharine Yao has written about Prognosis.
Katharine Yao
Connection Strength
1.819
Prognosis
  1. Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups. Breast Cancer Res Treat. 2015 Nov; 154(1):81-8.
    View in: PubMed
    Score: 0.295
  2. Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States. Cancer Med. 2020 05; 9(9):3088-3096.
    View in: PubMed
    Score: 0.100
  3. Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
    View in: PubMed
    Score: 0.096
  4. The "Nipple Whipple"?! A Pilot Study to Assess the Ergonomic Effects of Nipple-Sparing Mastectomy. Ann Surg Oncol. 2019 Oct; 26(10):3216-3223.
    View in: PubMed
    Score: 0.096
  5. Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers. Ann Surg Oncol. 2019 May; 26(5):1202-1211.
    View in: PubMed
    Score: 0.093
  6. Regional Variation in Performance for Commission on Cancer Breast Quality Measures and Impact on Overall Survival. Ann Surg Oncol. 2018 Oct; 25(10):3069-3075.
    View in: PubMed
    Score: 0.089
  7. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy. Ann Surg Oncol. 2018 Aug; 25(8):2220-2228.
    View in: PubMed
    Score: 0.088
  8. A Single Institution Retrospective Comparison Study of Locoregional Recurrence After Accelerated Partial Breast Irradiation Using External Beam Fractionation Compared with Whole Breast Irradiation with 8 Years of Follow-Up. Ann Surg Oncol. 2017 Oct; 24(10):2935-2942.
    View in: PubMed
    Score: 0.084
  9. The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer. Ann Surg Oncol. 2017 Oct; 24(11):3157-3166.
    View in: PubMed
    Score: 0.083
  10. Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S412-21.
    View in: PubMed
    Score: 0.073
  11. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Ann Surg Oncol. 2015 Dec; 22(13):4295-304.
    View in: PubMed
    Score: 0.071
  12. Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015 Mar; 22(3):899-907.
    View in: PubMed
    Score: 0.069
  13. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer. Ann Surg Oncol. 2014 Oct; 21(10):3231-9.
    View in: PubMed
    Score: 0.068
  14. Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2003-2011: report from the national cancer database. Ann Surg Oncol. 2014 Oct; 21(11):3457-65.
    View in: PubMed
    Score: 0.067
  15. Impact of bilateral versus unilateral mastectomy on short term outcomes and adjuvant therapy, 2003-2010: a report from the National Cancer Data Base. Ann Surg Oncol. 2014 Sep; 21(9):2920-7.
    View in: PubMed
    Score: 0.067
  16. Axillary surgery among estrogen receptor positive women 70 years of age or older with clinical stage I breast cancer, 2004-2010: a report from the National Cancer Data Base. Ann Surg Oncol. 2013 Oct; 20(10):3259-65.
    View in: PubMed
    Score: 0.064
  17. Accelerated partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer patients undergoing breast conservation, 2003-2010: a report from the national cancer data base. Ann Surg Oncol. 2013 Oct; 20(10):3223-32.
    View in: PubMed
    Score: 0.064
  18. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Ann Surg Oncol. 2013 Dec; 20(13):4113-20.
    View in: PubMed
    Score: 0.063
  19. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010 Oct; 17(10):2554-62.
    View in: PubMed
    Score: 0.051
  20. Notch-1 and notch-4 receptors as prognostic markers in breast cancer. Int J Surg Pathol. 2011 Oct; 19(5):607-13.
    View in: PubMed
    Score: 0.051
  21. Physician Knowledge of Breast Cancer Recurrence and Contralateral Breast Cancer Risk is Associated with Increased Recommendations for Contralateral Prophylactic Mastectomy: a Survey of Physicians at NAPBC-Accredited Centers. Ann Surg Oncol. 2019 Oct; 26(10):3080-3088.
    View in: PubMed
    Score: 0.024
  22. A Contemporary Analysis of Surgical Trends in the Treatment of Squamous Cell Carcinoma of the Oropharynx from 1998 to 2012: A Report from the National Cancer Database. Ann Surg Oncol. 2015 Dec; 22(13):4422-31.
    View in: PubMed
    Score: 0.018
  23. Peritumoral expression of adipokines and fatty acids in breast cancer. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S731-8.
    View in: PubMed
    Score: 0.016
  24. Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients. Ann Surg Oncol. 2012 Oct; 19(10):3257-63.
    View in: PubMed
    Score: 0.015
  25. Needle versus excisional biopsy for noninvasive and invasive breast cancer: report from the National Cancer Data Base, 2003-2008. Ann Surg Oncol. 2011 Dec; 18(13):3802-10.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.